Lu-177-Labeled Macroaggregated Albumin Imaging and Treatment Effect in Patient with Cystic Thyroid Nodule
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY, cilt.48, sa.1, ss.79-80, 2020 (ESCI, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 48 Sayı: 1
- Basım Tarihi: 2020
- Doi Numarası: 10.2967/jnmt.119.226340
- Dergi Adı: JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY
- Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, Agricultural & Environmental Science Database, Biotechnology Research Abstracts, CINAHL, EMBASE, MEDLINE
- Sayfa Sayıları: ss.79-80
- İstanbul Üniversitesi-Cerrahpaşa Adresli: Evet
Özet
A number of different peptides or antibodies have been labeled with Lu-177 and used for clinical imaging and treatment. To our knowledge, Lu-177 had never before been used to label macroaggregated albumin, and our radiopharmacy laboratory at Istanbul University-Cerrahpasa made a special effort to do so. We present the case of a 43-y-old man whose cystic thyroid nodule was treated with an intranodular injection of Lu-177-macroaggregated albumin and imaged with SPECT/CT.